Literature DB >> 3496972

Inverse relationship in H-2-associated lysis between NK cells and rIL-2-activated killer cells: evidence from in vitro killing and metastatic experiments.

A Toshitani, K Taniguchi, Y Kawano, K Nomoto.   

Abstract

We investigated the manner in which rIL-2 induced effectors in vitro (LAK cells), which, like NK cells, lyse targets nonspecifically and discriminate nonself, and how H-2 as the self-marker affects the LAK cell killing mechanism. NK cells showed an appreciably higher killing activity to B16 melanoma H-2- cells than to H-2+ cells. In contrast, LAK cells lysed more efficiently to H-2+ cells. The in vivo experiments showed that the NK cells prevented pulmonary metastasis of B16 H-2- cells in the normal syngeneic host, whereas the transferred LAK cells had a preferential inhibitory effect on the pulmonary metastasis of B16 H-2+ cells in the immunodeficient syngeneic hosts. Taken together, these results show that the H-2-encoded or H-2-associated molecules contribute to the triggering signal in the lysis by LAK cells, whereas the NK cells recognize the reduced self H-2 expression on the targets, thereby contributing to a trigger of the lysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496972     DOI: 10.1016/0008-8749(87)90203-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Effect of interferon gamma on the sensitivity of bovine-papilloma-virus(BPV1)-transformed cell lines to cell-mediated cytotoxicity.

Authors:  A Laatikainen; L Schultz-Suhonen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones.

Authors:  I Algarra; M Pérez; J J Gaforio; F Gasca; F Garrido
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

3.  Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours.

Authors:  I Algarra; A González; M Pérez; J J Gaforio; F Garrido
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

4.  Combination treatment with irritant and recombinant interleukin 2 in the peritoneal cavity for evoking effective anti-tumor activity: generation of lymphokine-activated killer cells and tumor-specific killer cells.

Authors:  H Uchida; K Taniguchi; K Nomoto
Journal:  Jpn J Cancer Res       Date:  1990-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.